Hispanic Broadcasting
Hispanic Broadcasting Newswire

Hispanic Broadcasting Newswire

Comprehensive Real-Time News Feed for Hispanic Broadcasting.

Results 1 - 20 of 247 in Hispanic Broadcasting

  1. Contract Manufacturing Is a Commercial Transaction for Purpose of...Read the original story w/Photo

    Friday Aug 28 | JD Supra

    Addressing the application of the on-sale bar under 102 , the U.S. Court of Appeals for the Federal Circuit found that the claims of an asserted patent were invalid based on an agreement, dated more than one year prior to the application filing date, to have a third party manufacture the patented drug. The Medicines Company v.

    Comment?

  2. Pfizer Nears Completion of Hospira AcquisitionRead the original story

    Wednesday Aug 26 | GuruFocus.com

    On Aug. 24 Pfizer, Inc. received clearance from the Federal Trade Commission for its acquisition of Hospira, Inc. . The acquisition process has been ongoing since Feb. 5 when Pfizer first announced it would be acquiring Hospira.

    Comment?

  3. Pfizer says Hospira purchase will close in early SeptemberRead the original story w/Photo

    Tuesday Aug 25 | The China Post

    Drugmaker Pfizer says it's received the final regulatory approvals for its US$15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September. The New York company said Monday regulators in the U.S. and Brazil cleared the deal.

    Comment?

  4. USA Today's '9 Stocks' story doesn't consider data essential to its narrative.Read the original story

    Tuesday Aug 25 | TheStreet.com

    As often happens when the market goes haywire, there's attempt to get as many what-can-I-do stories out as possible. And today's USA Today piece -- " Look out! 9 big stocks still aren't cheap ."

    Comment?

  5. Pfizer's Hospira deal gains U.S. approvalRead the original story w/Photo

    Monday Aug 24 | The Day

    Pfizer Inc. announced Monday that it has received final clearance in the United States and Brazil to complete its $15.2 billion acquisition of Hospira Inc. The U.S. Federal Trade Commission approved the acquisition, but is insisting that Pfizer sell off four of its U.S. sterile injectables: Acetylcysteine, Clindamycin, Voriconazole and Melphalan. Pfizer, seeking to become a leading pharmaceutical firm in the biosimilars market that offers cheaper alternatives to biologic drugs, announced the purchase of Hospira in February.

    Comment?

  6. FTC Requires Pfizer Inc. to Sell Rights to Four Products as a Condition of Acquiring Hospira, Inc.Read the original story

    Monday Aug 24 | Federal Trade Commission

    Pfizer is one of the world's largest drug companies and principally competes with Hospira in markets for certain sterile injectable pharmaceutical products. The FTC settlement order preserves competition by requiring the companies to divest the following products to the U.S.-based generic pharmaceutical company Alvogen Group Inc.: Pfizer's generic acetylcysteine inhalation solution.

    Comment?

  7. Pfizer Buy of Hospira Gets Green LightRead the original story w/Photo

    Monday Aug 24 | Wall Street Journal

    Pfizer Inc. on Monday said U.S. regulators have approved its acquisition of smaller rival Hospira Inc., pending the divestiture of some sterile injectable drugs, putting the deal on track to close in early September.

    Comment?

  8. Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira AcquisitionRead the original story

    Monday Aug 24 | Benzinga

    Pfizer Inc. today announced that the U.S. Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to Pfizer's pending acquisition of Hospira . The FTC's clearance is contingent upon Pfizer's commitment to divest four U.S. sterile injectable assets, including Acetylcysteine, Clindamycin, Voriconazole and Melphalan.

    Comment?

  9. Hargreaves Services plc Stock Rating Reaffirmed by N+1 SingerRead the original story

    Saturday Aug 22 | AmericanBankingNews.com

    's stock had its "corporate" rating reaffirmed by investment analysts at N+1 Singer in a note issued to investors on Tuesday, MarketBeat reports. Hargreaves Services plc traded down 0.41% during trading on Tuesday, reaching GBX 345.84.

    Comment?

  10. Hospira Release: Approves First mAb BiosimilarRead the original story

    Wednesday Aug 19 | BioSpace

    This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme .

    Comment?

  11. FDA's Cybersecurity Alert Puts Medical Device Users on NoticeRead the original story w/Photo

    Monday Aug 17 | JD Supra

    On July 31, 2015, the United States Food and Drug Administration issued a cybersecurity alert to health care facilities currently using certain infusion pumps manufactured by Hospira, Inc. The alert warns health care facilities about security vulnerabilities in Hospira's Symbiq Infusion System that could allow unauthorized access to the device and interfere with the device's proper functioning. The Hospira device communicates with a health care facility's network and information systems to control dosage delivery.

    Comment?

  12. Top Merger Stocks Held By Fund ManagersRead the original story w/Photo

    Sunday Aug 16 | Seeking Alpha

    Money managers who manage $100 million or more are required to make their portfolio public 45 days following the end of each quarter. That information can be valuable, and is followed closely by some investors, traders and the financial media.

    Comment?

  13. Hospira, Inc. (HSP) - Product Pipeline Analysis, 2015 UpdateRead the original story

    Saturday Aug 15 | Emailwire.com

    Most up-to-date research on "Hospira, Inc. - Product Pipeline Analysis, 2015 Update" to its huge collection of research reports. Product Synopsis Hospira , Inc. is a global specialty pharmaceutical and medication delivery company.

    Comment?

  14. Hospira, Inc. (HSP) - Product Pipeline Analysis, 2015 Update - Key...Read the original story w/Photo

    Friday Aug 14 | SBWire

    Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. It undertakes manufactures and markets products that help improve the safety and effectiveness and reduce the cost of patient care.

    Comment?

  15. Pfizer Granted Approval From The Canadian Competition Bureau For Hospira AcquisitionRead the original story

    Friday Aug 14 | Freshnews

    Pfizer Inc. today announced that it was granted approval from the Canadian Competition Bureau with respect to its pending acquisition of Hospira . As part of its agreement with the Canadian Competition Bureau, Pfizer has committed to divest certain assets in Canada.

    Comment?

  16. Pharmacy Technician's Vigilance Spurs Drug RecallRead the original story

    Thursday Aug 13 | ASHP

    Data from FDA suggest that responding to recalls-including the 1647 recalls of drug products and 992 biological product recalls that were initiated last year-is a routine part of hospital pharmacy practice. What may not be routine is for the vigilance of a staff member to precipitate a product recall, as was recently the case at the Johns Hopkins Hospital in Baltimore.

    Comment?

  17. Pfenex Reports Second Quarter 2015 Results And Provides Business UpdateRead the original story

    Wednesday Aug 12 | BioSpace

    Specifically, we look forward to updating you on progress for PF530, our biosimilar candidate to Betaseron later in 2015 as well as on PF708, our generic to Forteo, which we expect to enter bioequivalence studies in 2H15," stated , chief executive officer of Pfenex. "In April, we completed a follow-on offering with net proceeds to the company of approximately after the deduction of underwriter discounts and offering expenses.

    Comment?

  18. Pfizer Receives Approval From The Australian Competition And Consumer ...Read the original story

    Wednesday Aug 12 | BioSpace

    Pfizer Inc. today announced that the Australian Competition and Consumer Commission has approved the company's pending acquisition of Hospira, Inc. and found no need for remedies. "We are pleased to have achieved another significant milestone for Pfizer's pending acquisition of Hospira with the ACCC's approval of the transaction" "We are pleased to have achieved another significant milestone for Pfizer's pending acquisition of Hospira with the ACCC's approval of the transaction," said Ian Read, chairman and chief executive officer, Pfizer.

    Comment?

  19. Hospira Applauds UK's NICE for Issuing Adoption Resource to Help ...Read the original story

    Thursday Aug 13 | Sys-Con Media

    The recently published adoption resource entitled, " Introducing biosimilar versions of infliximab: Inflectra and Remsima ," provides practical advice on how to effectively introduce biosimilars into clinical practice, as well as a process to implement a well-managed and safe switching program from reference biologics to biosimilars. Through case studies, the resource highlights how biosimilars can help lead to a more sustainable healthcare system and can help improve patient access to high cost biologic medicines.

    Comment?

  20. Hospira, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportRead the original story

    Wednesday Aug 12 | PR-inside.com

    Recently published research from MarketLine, "Hospira, Inc. - Mergers & Acquisitions , Partnerships & Alliances and Investment Report", is now available at Fast Market Research MarketLine's Company Mergers & Acquisitions , Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

    Comment?